EMPE Diagnostics is an interdisciplinary R&D-based biotechnology company that develops rapid diagnostic solutions for infectious diseases with a special focus on Tuberculosis and Sexually Transmitted Infections. EMPE's internationally unique rapid tests can correctly identify virus or bacteria and their antimicrobial resistance within 2 h. We primarily focus on Tuberculosis and provide confirmatory clinical results by developing visual signals without requiring special instruments.

EMPE’s diagnostic solutions brings the diagnosis time from months to minutes at an affordable cost that can reduce the hidden danger of antibiotic resistance. We aim to help clinicians in over 200 countries to start immediate treatment, even at primary health care centers and medical camps, with appropriate antibiotics.